Arlington to sell medical device firm Riverpoint Medical for $1.2bn
Tuesday, June 9, 2026 · first reported by PE Hub
Arlington exits portfolio company Riverpoint Medical in $1.2bn sale closing Q3 2026.
- Firm
- Arlington
- Deal value
- $1.2B
- Asset class
- Private equity
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore in Deals
From the same day- CapMan Growth exits eye health company Silmäasema for €574mPE Hub
- Thoma Bravo to take validation software firm Kneat private for $466mPE Hub
- Bain Capital joins competitive bidding process for Australia’s oOh!mediaPrivate Equity Wire
- Clearlake snaps up private markets firm Pathway CapitalPE Hub
- Archimed acquires PET radiopharmaceuticals company IRABPE Hub
- Gemspring backs motorcycle parts retailer ComotoPE Hub